Results 131 to 140 of about 3,568 (149)

[Research progress on the quercetin target role and signaling pathway in anti-liver fibrosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhao RQ, Liu HY, Yan JM, Hao Y, Ding YX, Zhang F, Zhou RM, Zhao R, Bai F, Bai WF.   +9 more
europepmc   +1 more source

[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ren S, Zheng SJ, Chen XY.
europepmc   +1 more source

[Advances in the construction and application of a novel liver organoid model for hepatitis B virus infection]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li H, Xiang KH.
europepmc   +1 more source

[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Guo X, Fan PY, Li J, Wang LX, Dong Y, Cao LL, Yan JG, Zhang M, Wang FS.   +8 more
europepmc   +1 more source

[Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li XR, Niu B, Zhang LY.
europepmc   +1 more source

[EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xu J, Yang D, Zang K, Chu M, Zhao Q, Li Q, Lu S, Chen X, Li N.   +8 more
europepmc   +1 more source

[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhuang H.
europepmc   +1 more source

[A dual-center study of enhanced CT-based nomograms predicts spontaneous portosystemic shunts on initial hemorrhage from rupture of esophageal gastric varices in cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Yan XZ, Chu JH, Li B, Chen XY, Yuan BS, Li HY, Wang GL, Ji Q.   +7 more
europepmc   +1 more source

[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang ZW, Dong Y, Ouyang WX, Cao LL, Pang L, Xu HM, Yan JG, Zhu Y, Xu Y, Fu JL, Wang FS, Zhang M.   +11 more
europepmc   +1 more source